NEW DELHI : Drug firm Torrent Pharmaceuticals on Tuesday reported a consolidated net profit of ₹314 crore for the quarter ended March 31, mainly on account of cost control and productivity improvements.
The company had posted a net loss of ₹152 crore for the corresponding period of the previous financial year, Torrent Pharma said in a filing to the BSE.
Its consolidated revenue from operations stood at ₹1,946 crore for the quarter under consideration as against ₹1,856 crore for the corresponding period a year ago, it added.
For the financial year ended March this year, the net profit of the company was at ₹1,025 crore. It was ₹436 crore for the previous fiscal year, Torrent Pharma said.
Read more on livemint.com